Follow us on:
Every month, the European Medicines Agency shares key information relating to medicines for human use β including positive opinions and authorizations for hematologic medicinal products. Find the latest updates here: bit.ly/EMA_news
This week's featured Immunotherapy Net #scipub: 'Risk-Adapted Preemptive #Tocilizumab to Prevent Severe #CRS After CTL019 for Pediatric B-Cell #ALL: A Prospective Clinical Trial' (π πππͺπ― ππ―π€π°π). πBrowse all publications: bit.ly/EurImmunoNet_Pβ¦